Bisphosphonate-Induced Avascular Osteonecrosis of the Mandible Associated With a Common Thrombophilic Mutation in the Prothrombin Gene

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 9, 2009, Pages 2009-2012

  Vairaktaris, Eleftherios ^a   Vassiliou, Stavros ^a   Avgoustidis, Dimitrios ^a   Stathopoulos, Panagiotis ^a   Toyoshima, Takeshi ^b   Yapijakis, Christos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PROTHROMBIN;

AGED; ANAMNESIS; ARTICLE; BLOOD SAMPLING; BONE NECROSIS; CASE REPORT; FEMALE; GENE MUTATION; GRANULATION TISSUE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; JAW OSTEONECROSIS; MANDIBLE RESECTION; MOUTH EXAMINATION; PANORAMIC RADIOGRAPHY; PEDIGREE ANALYSIS; POSTOPERATIVE INFECTION; PREMOLAR TOOTH; RECURRENT DISEASE; SUTURING METHOD; THROMBOCYTE RICH PLASMA; THROMBOPHILIA;

AGED; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DEBRIDEMENT; DIPHOSPHONATES; FEMALE; HUMANS; MANDIBLE; MANDIBULAR DISEASES; MUTATION; OSTEONECROSIS; PEDIGREE; PLATELET-RICH PLASMA; PROTHROMBIN; THROMBOPHILIA; TOOTH EXTRACTION;

EID: 68549085211     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.04.032     Document Type: Article

References (24)

1. Merigo E., Manfredi M., Meleti M., et al. Bone necrosis of the jaws associated with bisphosphonate treatment: A report of twenty-nine cases. Acta Biol Med 77 (2006) 109
2. Curi M.M., Cossolin G.S.I., Koga D.H., et al. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonates therapy by combining bone resection and autologous platelet-rich-plasma: Report of 3 cases. J Oral Maxillofac Surg 65 (2007) 349
3. Ruggiero S.I., Mebrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527
4. Gering A., Grange L., Villier C., et al. Bisphosphonates-associated osteonecrosis of the jaw: Review on reported cases. Therapie 62 (2007) 49
5. Woo S.B., Helletein J.W., and Kalmar J.R. Narrative (corrected) review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753
6. Assael L.A. A time for perspective on bisphosphonates. J Oral Maxillofac Surg 64 (2006) 877
7. Wang J., Goodger N.M., and Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61 (2003) 1104
8. Melo M.D., and Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonates therapy. J Can Dent Assoc 71 (2005) 111
9. Carter G.D., and Goss N.A. Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48 (2003) 268
10. Migliorati C.A. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253
11. Glueck C.J., McMachon R.E., Bouquot J., et al. Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 (2003) 557 557
12. Bertina R.M., Koeleman B.P., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64
13. Ridker P.M., Hennekens C.H., and Miletich J.P. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 99 (1999) 999
14. Vairaktaris E., Yapijakis C., Wiltfang J., et al. Are factor V and prothrombin mutations associated with increased risk of oral cancer?. Anticancer Res 25 (2005) 2561
15. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111
16. Vairaktaris E., Yapijakis C., Kessler P., et al. Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132 (2006) 219
17. Dannemann C., Grätz K.W., Zwablen R., et al. Clinical experience with bisphosphonates-induced osteochemonecrosis of the jaws. Swiss Med Wkly 136 (2006) 504
18. Body J.J. Breast cancer: Bisphosphonates therapy for metastatic bone disease. Clin Cancer Res 12 (2006) 6258
19. Santini D., Vincenzi B., Avvisati G., et al. Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 8 (2002) 1080
20. Glueck C.J., McMachon R.E., Bouquot J., et al. A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radol Endod 85 (1998) 64
21. Glueck C.J., McMachon R.E., Bouquot J., et al. Heterozygosity for the Leiden mutation of the factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens. J Lab Clin Med 130 (1997) 540
22. Greenberg M.S. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 259
23. Marx R.E., Carlson E.R., Eichstaedt R.M., et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638
24. Dugrillon A., Eichler H., Kern S., et al. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31 (2002) 615